$AHRO
Authentic Holdings, Inc. Stock $ahro

$ahro Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000147793224003655 Filed on June 12, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$27.33K	$0.00	$0.00
YoY Change
Cost Of Revenue	$11.50K	$0.00	$0.00
YoY Change
Gross Profit	$15.83K	$0.00	$0.00
YoY Change
Gross Profit Margin	57.92%
Selling, General & Admin	$69.72K	$45.70K	$303.4K
YoY Change	-36.62%		16.7%
% of Gross Profit	440.37%
Research & Development	$0.00	$2.000K	$56.86K
YoY Change	-100.0%	-97.14%	-12.95%
% of Gross Profit	0.0%
Depreciation & Amortization	$136.7K	$270.6K	$46.49K
YoY Change	1266.5%	2606.4%	-3.62%
% of Gross Profit	863.13%
Operating Expenses	$206.4K	$312.1K	$660.9K
YoY Change	83.64%	290.11%	59.24%
Operating Profit	-$190.5K	-$312.1K	-$660.9K
YoY Change	69.55%	290.11%	59.24%
Interest Expense	$1.151M	-$55.64K	-$608.0K
YoY Change	-2.49%	-94.55%	-18.93%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$62.04K	-$997.5K
YoY Change	-100.0%		-10331.23%
Pretax Income	$0.00	-$711.1K	-$1.658M
YoY Change	-100.0%	-35.36%	42.97%
Income Tax
% Of Pretax Income
Net Earnings	$920.1K	-$711.1K	-$1.658M
YoY Change	-504.38%	-35.36%	43.24%
Net Earnings / Revenue	3366.35%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	2.240B shares	1.978B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$0.00
YoY Change	-100.0%
Cash & Equivalents	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$625.0K	$625.0K
YoY Change	38.89%	-0.79%
Inventory
Prepaid Expenses
Receivables		$0.00
Other Receivables
Total Short-Term Assets	$625.0K	$625.0K
YoY Change	35.92%	0.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$154.00	$21.72K
YoY Change	-99.66%	-68.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.520M	$4.793M
YoY Change	6993.48%	5429.65%
TOTAL ASSETS
Total Short-Term Assets	$625.0K	$625.0K
Total Long-Term Assets	$4.520M	$4.793M
Total Assets	$5.145M	$5.418M
YoY Change	882.76%	661.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$366.5K	$316.9K
YoY Change	59.33%	37.77%
Accrued Expenses	$501.3K	$501.3K
YoY Change	0.25%	0.25%
Deferred Revenue
YoY Change
Short-Term Debt	$2.707M	$2.612M
YoY Change	12.79%	4.47%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.201M	$5.624M
YoY Change	7.06%	7.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.201M	$5.624M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$5.201M	$5.624M
YoY Change	7.02%	7.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.19M	-$38.04M
YoY Change	4.32%	4.56%
Common Stock	$2.240M	$2.024M
YoY Change	19.43%	29.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$55.96K	-$205.5K
YoY Change
Total Liabilities & Shareholders Equity	$5.145M	$5.418M
YoY Change	882.76%	661.3%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$920.1K	-$711.1K	-$1.658M
YoY Change	-504.38%	-35.36%	43.24%
Depreciation, Depletion And Amortization	$136.7K	$270.6K	$46.49K
YoY Change	1266.5%	2606.4%	-3.62%
Cash From Operating Activities	-$52.27K	$42.77K	-$227.2K
YoY Change	-75.11%	-161.1%	-77.3%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	52.27K	-42.77K	$227.2K
YoY Change	-76.24%	-171.28%	-77.39%
NET CHANGE
Cash From Operating Activities	-52.27K	42.77K	-$227.2K
Cash From Investing Activities	0.000	0.000	$0.00
Cash From Financing Activities	52.27K	-42.77K	$227.2K
Net Change In Cash	0.000	0.000	$0.00
YoY Change	-100.0%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$52.27K	$42.77K	-$227.2K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$52.27K	$42.77K	-$227.2K
YoY Change		-161.1%	-77.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2024420237	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the valuation of stock-based awards issued and derivatives embedded in financial instruments. Assessments are used to determine depreciation, the valuation of non-cash issuances of common stock, stock options, and warrants, and valuing convertible notes for beneficial conversion features, among others.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The carrying value of short-term financial instruments, including cash, restricted cash, trade accounts receivable, accounts payable, accrued expenses, and short-term debt, approximates the fair value of these instruments. These financial instruments generally expose the Company to limited credit risk and have no stated maturities or have short-term maturities and carry interest rates that approximate the market. The Company maintains cash balances at financial institutions insured by the FDIC. On December 31, 2023, and December 31, 2022, the Company had no amounts above the FDIC limit.</p>
CY2023Q4	ahro	Advances Current AdvancesCurrent	625000	usd
CY2022Q4	ahro	Advances Current AdvancesCurrent	625000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	625000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18473	usd
CY2023Q4	us-gaap	Assets Assets	5418043	usd
CY2022Q4	us-gaap	Assets Assets	711679	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	1814	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	306	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	316873	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	234641	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1633052	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1608485	usd
CY2023Q4	ahro	Advances From Related Parties Current AdvancesFromRelatedPartiesCurrent	560779	usd
CY2022Q4	ahro	Advances From Related Parties Current AdvancesFromRelatedPartiesCurrent	383686	usd
CY2023Q4	ahro	Related Party Loans And Accrued Interest Current RelatedPartyLoansAndAccruedInterestCurrent	274456	usd
CY2022Q4	ahro	Related Party Loans And Accrued Interest Current RelatedPartyLoansAndAccruedInterestCurrent	263530	usd
CY2023Q4	ahro	Self Liquidating Promissory Notes SelfLiquidatingPromissoryNotes	192500	usd
CY2022Q4	ahro	Self Liquidating Promissory Notes SelfLiquidatingPromissoryNotes	165000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5623581	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5228481	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1557397662	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1557397	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-205538	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	91226	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	130345	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	94255	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56858	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65315	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	660910	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1658455	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1157783	usd
CY2023	ahro	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	1847673383	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-1157783	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	24567	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	549957	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46485	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	219385	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	134792	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-227228	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4022	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4022	usd
CY2023	ahro	Advances From Related Parties AdvancesFromRelatedParties	17790	usd
CY2022	ahro	Advances From Related Parties AdvancesFromRelatedParties	18989	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	35000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	97965	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	25000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q4	ahro	Working Capital Deficit WorkingCapitalDeficit	-4603481	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240853	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240853	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	219132	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	172648	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21721	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68206	usd
CY2023	us-gaap	Depreciation Depreciation	46484	usd
CY2022	us-gaap	Depreciation Depreciation	48233	usd
CY2023	ahro	Amortization For The Intangible Assets AmortizationForTheIntangibleAssets	5155096	usd
CY2022	ahro	Amortization For The Intangible Assets AmortizationForTheIntangibleAssets	148096	usd
CY2023	ahro	Less Accumulated Amortization LessAccumulatedAmortization	-383774	usd
CY2022	ahro	Less Accumulated Amortization LessAccumulatedAmortization	-129623	usd
CY2023	ahro	Amortization For The Intangible Assets Net AmortizationForTheIntangibleAssetsNet	4771322	usd
CY2022	ahro	Amortization For The Intangible Assets Net AmortizationForTheIntangibleAssetsNet	18473	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1633052	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1608485	usd
CY2023Q4	ahro	Accrued Interest AccruedInterest	60250	usd
CY2022Q4	ahro	Accrued Interest AccruedInterest	103264	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1608485	usd
CY2023	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	24567	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1633052	usd
CY2023	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	operating lease for an office premise had expired on October 1 and the lease was not renewed
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1601	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2433029215	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	110762210	shares
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001338929
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3500000000	shares
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-52047
CY2023	dei	Entity Registrant Name EntityRegistrantName	AUTHENTIC HOLDINGS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3746201
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	50 Division Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Somerset
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08873
CY2023	dei	City Area Code CityAreaCode	732
CY2023	dei	Local Phone Number LocalPhoneNumber	695-4389
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1963367	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2240073721	shares
CY2023	dei	Auditor Name AuditorName	Victor Mokuolu, CPA PLLC
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023	dei	Auditor Firm AuditorFirmId	6771
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	625000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21721	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68206	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4771322	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	501250	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	501250	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	159950	usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt	250464	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1320858	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1243243	usd
CY2023Q4	ahro	Related Party Transaction Amounts Of Convertible Notes And Accrued Interest RelatedPartyTransactionAmountsOfConvertibleNotesAndAccruedInterest	87068	usd
CY2022Q4	ahro	Related Party Transaction Amounts Of Convertible Notes And Accrued Interest RelatedPartyTransactionAmountsOfConvertibleNotesAndAccruedInterest	82568	usd
CY2023Q4	ahro	Secured Promisory Notesand Accrued Interest SecuredPromisoryNotesandAccruedInterest	41022	usd
CY2022Q4	ahro	Secured Promisory Notesand Accrued Interest SecuredPromisoryNotesandAccruedInterest	0	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Debt And Accrued Interest LiabilitiesSubjectToCompromiseDebtAndAccruedInterest	25000	usd
CY2022Q4	us-gaap	Liabilities Subject To Compromise Debt And Accrued Interest LiabilitiesSubjectToCompromiseDebtAndAccruedInterest	0	usd
CY2023Q4	ahro	Related Party Transaction Amounts Of Promissory Note And Accrued Interest RelatedPartyTransactionAmountsOfPromissoryNoteAndAccruedInterest	508959	usd
CY2022Q4	ahro	Related Party Transaction Amounts Of Promissory Note And Accrued Interest RelatedPartyTransactionAmountsOfPromissoryNoteAndAccruedInterest	495308	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2024420	usd
CY2023Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	16500	usd
CY2022Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35791910	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30305914	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38038768	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36380313	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4516802	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5418043	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	711679	usd
CY2023	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Revenues Revenues	0	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023	us-gaap	Gross Profit GrossProfit	0	usd
CY2022	us-gaap	Gross Profit GrossProfit	0	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	173072	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	164252	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300635	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	415048	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-660910	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-415048	usd
CY2023	ahro	Income Loss On Change In Fair Value Of Derivative Liabilities IncomeLossOnChangeInFairValueOfDerivativeLiabilities	-24567	usd
CY2022	ahro	Income Loss On Change In Fair Value Of Derivative Liabilities IncomeLossOnChangeInFairValueOfDerivativeLiabilities	-549957	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-239028	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-452472	usd
CY2022	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	15856	usd
CY2023	ahro	Gain On Settlement Of License Agreements GainOnSettlementOfLicenseAgreements	125000	usd
CY2022	ahro	Gain On Settlement Of License Agreements GainOnSettlementOfLicenseAgreements	0	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	318796	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	116728	usd
CY2023	ahro	Interest Expense Related Partie InterestExpenseRelatedPartie	25647	usd
CY2022	ahro	Interest Expense Related Partie InterestExpenseRelatedPartie	82156	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-62035	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9750	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-997545	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-742735	usd
CY2022	ahro	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	1557397662	shares
CY2023	ahro	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.001
CY2022	ahro	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.001
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3679390	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	255370	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	65001	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1157783	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4516802	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4516802	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7000	usd
CY2023	ahro	Stock Issued During Period Shares For License Agreement With Goliath Amount StockIssuedDuringPeriodSharesForLicenseAgreementWithGoliathAmount	5000000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	641703	usd
CY2023	ahro	Extinguishment Of Derivative Liabilities ExtinguishmentOfDerivativeLiabilities	259374	usd
CY2023	ahro	Commitment Shares Issued CommitmentSharesIssued	26642	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	35000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1658455	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-205538	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1658455	usd
CY2023	ahro	Loss On Conversion Of Convertible Debt LossOnConversionOfConvertibleDebt	452472	usd
CY2022	ahro	Loss On Conversion Of Convertible Debt LossOnConversionOfConvertibleDebt	48313	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48233	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	254151	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	42993	usd
CY2023	ahro	Extinguishment Of Derivative Expenses ExtinguishmentOfDerivativeExpenses	239028	usd
CY2022	ahro	Extinguishment Of Derivative Expenses ExtinguishmentOfDerivativeExpenses	0	usd
CY2023	ahro	Adjustments To Commitment Shares Issued AdjustmentsToCommitmentSharesIssued	26642	usd
CY2022	ahro	Adjustments To Commitment Shares Issued AdjustmentsToCommitmentSharesIssued	0	usd
CY2023	ahro	Increase Decrease In Advances To Joint Venture IncreaseDecreaseInAdvancesToJointVenture	0	usd
CY2022	ahro	Increase Decrease In Advances To Joint Venture IncreaseDecreaseInAdvancesToJointVenture	625000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	168497	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-40210	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-998705	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	1508	usd
CY2022	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-2149	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	40000	usd
CY2022	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	147750	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	887922	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-39820	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	227228	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1002727	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	0	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	ahro	Conversion Of Convertible Debt Into Common Stock ConversionOfConvertibleDebtIntoCommonStock	641703	usd
CY2022	ahro	Conversion Of Convertible Debt Into Common Stock ConversionOfConvertibleDebtIntoCommonStock	255370	usd
CY2023	ahro	Preferred Shares Issued For Acquisition Of Maybacks PreferredSharesIssuedForAcquisitionOfMaybacks	7000	usd
CY2022	ahro	Preferred Shares Issued For Acquisition Of Maybacks PreferredSharesIssuedForAcquisitionOfMaybacks	0	usd
CY2023	ahro	Preferred Shares Issue For Acquisition Of License PreferredSharesIssueForAcquisitionOfLicense	5000000	usd
CY2022	ahro	Preferred Shares Issue For Acquisition Of License PreferredSharesIssueForAcquisitionOfLicense	0	usd
CY2023Q2	ahro	Finite Lived Intangible Asset Estimate Useful Life FiniteLivedIntangibleAssetEstimateUsefulLife	P10Y
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38038768	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36380313	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1658455	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1157783	usd
CY2023Q4	ahro	Working Capital Deficit WorkingCapitalDeficit	-4998581	usd
CY2023Q4	ahro	Unsecured Note Payable UnsecuredNotePayable	99700	usd
CY2022Q4	ahro	Unsecured Note Payable UnsecuredNotePayable	147200	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	254151	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	42993	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2024420237	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1557397662	shares
CY2023Q4	ahro	Issuance Of Common Stock Shares IssuanceOfCommonStockShares	15000000	shares
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	159950	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	250464	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1061793	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1166738	usd
CY2023Q4	ahro	Convertible Note Payable Discount ConvertibleNotePayableDiscount	-36921	usd
CY2022Q4	ahro	Convertible Note Payable Discount ConvertibleNotePayableDiscount	-92000	usd
CY2023Q4	ahro	Accrued Interestate AccruedInterestate	295986	usd
CY2022Q4	ahro	Accrued Interestate AccruedInterestate	168505	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1320858	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1243243	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1058528	usd
CY2022	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	549957	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year One PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne	500700	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Two PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo	500700	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Three PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree	500700	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Four PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFour	500700	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Five PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFive	500700	usd
CY2023Q4	ahro	Present Value Of Future Insurance Profits Amortization Expense PresentValueOfFutureInsuranceProfitsAmortizationExpense	2503500	usd
CY2023Q4	ahro	Present Value Of Future Insurance Profits Amortization Expense Year Thereafter PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThereafter	2253150	usd
CY2023Q4	ahro	Total Estimated Future Amortization TotalEstimatedFutureAmortization	4756650	usd
CY2023	ahro	Net Cash Proceeds NetCashProceeds	23290	usd
CY2022	ahro	Net Cash Proceeds NetCashProceeds	18989	usd
CY2023	ahro	Advances From Related Parties Debt AdvancesFromRelatedPartiesDebt	560779	usd
CY2022	ahro	Advances From Related Parties Debt AdvancesFromRelatedPartiesDebt	383686	usd
CY2023Q4	ahro	Related Party Transaction Amounts Of Promissory Note And Accrued Interest RelatedPartyTransactionAmountsOfPromissoryNoteAndAccruedInterest	508959	usd
CY2023Q4	ahro	Related Party Transaction Amounts Of Convertible Notes And Accrued Interest RelatedPartyTransactionAmountsOfConvertibleNotesAndAccruedInterest	87068	usd
CY2023Q4	ahro	Related Party Transaction Amounts Of Related Party Loans RelatedPartyTransactionAmountsOfRelatedPartyLoans	274457	usd
CY2023Q4	ahro	Related Party Transaction Amounts Of Total Related Parties Loans RelatedPartyTransactionAmountsOfTotalRelatedPartiesLoans	870483	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	29077	usd
CY2023Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	841215	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	501250	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38038768	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36380313	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7988141	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7639866	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	7988141	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	7639866	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	38000000	usd
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s net operating loss carry forwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2019 through 2023 are subject to review by the tax authorities
CY2023	ahro	Proceeds From Secured Promissory Notes ProceedsFromSecuredPromissoryNotes	43000	usd

Files In Submission

Name	View Source	Status
0001477932-24-003655-index-headers.html	Edgar Link	pending
0001477932-24-003655-index.html	Edgar Link	pending
0001477932-24-003655.txt	Edgar Link	pending
0001477932-24-003655-xbrl.zip	Edgar Link	pending
ahro-20231231.xsd	Edgar Link	pending
ahro_10k.htm	Edgar Link	pending
ahro_10kimg1.jpg	Edgar Link	pending
ahro_10kimg2.jpg	Edgar Link	pending
ahro_10kimg3.jpg	Edgar Link	pending
ahro_10kimg4.jpg	Edgar Link	pending
ahro_10kimg5.jpg	Edgar Link	pending
ahro_ex311.htm	Edgar Link	pending
ahro_ex312.htm	Edgar Link	pending
ahro_ex321.htm	Edgar Link	pending
ahro_ex322.htm	Edgar Link	pending
ahro_ex41.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
ahro-20231231_lab.xml	Edgar Link	unprocessable
ahro_10k_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ahro-20231231_cal.xml	Edgar Link	unprocessable
ahro-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ahro-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHRO
Authentic Holdings, Inc. Stock $ahro

2024 Q2 Form 10-K Financial Statement

#000147793224003655 Filed on June 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHRO Authentic Holdings, Inc. Stock $ahro

2024 Q2 Form 10-K Financial Statement

#000147793224003655 Filed on June 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHRO
Authentic Holdings, Inc. Stock $ahro